Best Practice & Research Clinical Rheumatology
Volume 23, Issue 5 , Pages 689-697 , October 2009

Atypical and incomplete Kawasaki disease

  • R. Cimaz, MD Head, Rheumatology Department

      Affiliations

    • AOU Meyer and University of Florence, Viale Pieraccini 24, 50139 Florence, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 055 5662924; Fax: +39 055 5662400.
    • ,
  • R. Sundel, MD Head, Rheumatology Department

      Affiliations

    • Children's Hospital Boston and Harvard Medical School, 300 Longwood Avenue, Boston MA 02115, USA
    • Tel.: +617 355 6524; Fax: +617 730 0249.

References 

  1. Kawasaki T, Kosaki F, Okawa S, et al. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974;54:271–276
  2. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki Disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on cardiovascular disease in the young, American Heart Association. Pediatrics. 2004;114:1708–1733
  3. Ozen S, Ruperto N, Dillon MJ, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65:936–941
  4. Burns JC, Kushner HI, Bastian JF, et al. Kawasaki disease: a brief history. Pediatrics. 2000;106:e27
  5. Levy M, Koren G. Atypical Kawasaki disease: analysis of clinical presentation and diagnostic clues. Pediatr Infect Dis J. 1990;9:122–126
  6. Anderson MS, Todd JK, Glode MP. Delayed diagnosis of Kawasaki syndrome: an analysis of the problem. Pediatrics. 2005;115:e428
  7. Genizi J, Miron D, Spiegel R, et al. Kawasaki disease in very young infants: high prevalence of atypical presentation and coronary arteritis. Clin Pediatr (Phila). 2003;42:263–267
  8. Fukushige J, Takahashi N, Ueda Y, Ueda K. Incidence and clinical features of incomplete Kawasaki disease. Acta Paediatr. 1994;83:1057–1060
  9. Burns JC, Mason WH, Glode MP, et al. Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. J Pediatr. 1991;118:680–686
  10. Komatsu H, Tateno A. Failure to distinguish systemic-onset juvenile idiopathic arthritis from incomplete Kawasaki disease in an infant. J Paediatr Child Health. 2007;43:707–709
  11. Binstadt BA, Levine JC, Nigrovic PA, et al. Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic arthritis. Pediatrics. 2005;116:e89–e93
  12. Valentini P, Ausili E, Schiavino A, et al. Acute cholestasis: atypical onset of Kawasaki disease. Dig Liver Dis. 2008;40:582–584
  13. Elizabet KE, Zulfikar Ahamed M, Praaven KS. Atypical relapsing course of Kawasaki Disease with hemorrhagic serous effusions and hepatic dysfunction. Indian Pediatr. 2007;44:785–787
  14. Munro AR, Beasley SW, Pattemore PK, Fraser R. Fatal late onset necrotising enterocolitis in a term infant: atypical Kawasaki disease or polyarteritis nodosa of infancy?. J Paediatr Child Health. 2003;39:555–557
  15. Ravinder S, Ward C, Walton M, Persad R. Atypical Kawasaki disease and gastrointestinal manifestation. Paediatr Child Health. 2007;12:235–237
  16. Beiler HA, Schmidt KG, von Herbay A, et al. Ischemic small bowel strictures in a case of incomplete Kawasaki Disease. J Pediatr Surg. 2001;36:648–650
  17. Zulian F, Falcini F, Zancan L, et al. Acute surgical abdomen as presenting manifestation of Kawasaki Disease. J Pediatr. 2003;142:731–735
  18. Bosch Marcet J, Serres Creixams X, Penas Boira M, Inaraja Martınez L. Mediastinal lymphadenopathy: a variant of incomplete Kawasaki disease. Acta Pædiatr. 1998;87:1200–1202
  19. Falcini F, Simonini G, Calabri GB, Cimaz R. Multifocal lymphadenopathy associated with severe Kawasaki disease: a difficult diagnosis. Ann Rheum Dis. 2003;62:688–689
  20. Langley EW, Kirse DK, Barnes CE, et al. Retropharyngeal edema: an unusual manifestation of Kawasaki disease. J Emerg Med. 2009 Jan 14;[Epub ahead of print]
  21. Runel-Belliard C, Lasserre S, Quinet B, Grimprel E. Febrile torticollis: an atypical presentation of Kawasaki disease. Arch Pediatr. 2009;16:115–117
  22. Wright H, Waddington C, Geddes J, et al. Facial nerve palsy complicating Kawasaki Disease. Pediatrics. 2008;122:783–785
  23. Kleiman MB, Passo MH. Incomplete Kawasaki disease with facial nerve paralysis and coronary artery involvement. Pediatr Infect Dis J. 1988;7:301–302
  24. Dengler LD, Capparelli EV, Bastian JF, et al. Cerebrospinal fluid profile in patients with acute Kawasaki disease. Pediatr Infect Dis J. 1998;17:478–481
  25. Sundel RP, Cleveland SS, Beiser AS, et al. Audiologic profiles of children with Kawasaki disease. Am J Otol. 1992;13:512–515
  26. Knott PD, Orloff LA, Harris JP, et al. Kawasaki Disease Multicenter Hearing Loss Study Group Sensorineural hearing loss and Kawasaki disease: a prospective study. Am J Otol. 2001;22:343–348
  27. Sundel RP, Newburger JW, McGill T, et al. Sensorineural hearing loss associated with Kawasaki disease. J Pediatr. 1990;117:371–377
  28. Uziel Y, Hashkes PJ, Kassem E, et al. “Unresolving pneumonia” as the main manifestation of atypical Kawasaki disease. Arch Dis Child. 2003;88:940–942
  29. Falcini F, Vitale A, La Torre F, et al. Refractory pneumonia and high fever. Lancet. 2009;373:1818
  30. Freeman AF, Crawford SE, Finn LS, et al. Inflammatory pulmonary nodules in Kawasaki disease. Pediatr Pulmonol. 2003;36:102–106
  31. Papadodima SA, Sakelliadis EI, Goutas ND, et al. Atypical Kawasaki disease presenting with symptoms from the genitourinary system: an autopsy report. J Trop Pediatr. 2009;55:55–57
  32. Kabani A, Joffe A, Jadavji T. Hydrocele in Kawasaki disease: importance in early recognition of atypical disease. Am J Dis Child. 1991;145:1349–1351
  33. Wu CY, Hsieh KS, Chiou YH, et al. Prolonged fever and pyuria: a urinary tract infection presentation of incomplete Kawasaki disease. Acta Paediatr. 2005;94:375–377
  34. Falcini F, Calabri GB, Simonini G, et al. Bilateral renal artery stenosis in Kawasaki disease: a report of two cases. Clin Exp Rheumatol. 2006;24:719–721
  35. Sinha R, Balakumar T. BCG reactivation: a useful diagnostic tool even for incomplete Kawasaki disease. Arch Dis Child. 2005;90:891
  36. Yamazaki-Nakashimada MA, Ramırez-Vargas N, De Rubens-Figueroa J. Chronic granulomatous disease associated with atypical Kawasaki Disease. Pediatr Cardiol. 2008;29:169–171
  37. Kadayan A, Choi J, Headon MP. Disciform keratitis and optic disc swelling in Kawasaki disease: an unusual presentation. Eye. 2006;20:976–977
  38. Anand S, Yang YC. Optic disc changes in Kawasaki disease. J Pediatr Ophtalmol Strabismus. 2004;41:177–179
  39. Purvin V, Kawasaki A, Jacobson DM. Optic perineuritis: clinical and radiographic features. Arch Ophtalmol. 2001;1299–1306
  40. Ohono S, Miyajima T, Higuci M, et al. Ocular manifestations of Kawasaki disease. Am J Ophthalmol. 1982;93:713–717
  41. Blatt AN, Vogler L, Tychsen L. Incomplete presentations in a series of 37 children with Kawasaki disease: the role of the pediatric ophthalmologist. J Pediatr Ophthalmol Strabismus. 1996;33:114–119
  42. Cummings C, McCarthy P, van Hoff J, Porter G. Kawasaki disease associated with reactive hemophagocytic lymphohistiocytosis. Pediatr Infect Dis J. 2008;27:1116–1118
  43. Muise A, Tallett SE, Silverman ED. Are children with Kawasaki disease and prolonged fever at risk for macrophage activation syndrome?. Pediatrics. 2003;112:e495
  44. Palazzi DL, McClain KL, Kaplan SL. Hemophagocytic syndrome after Kawasaki disease. Pediatr Infect Dis J. 2003;22:636–66
  45. Kanegaye JT, Wilder MS, Molkara D, et al. Recognition of a Kawasaki Disease Shock Syndrome. Pediatrics. 2009;123:e783–e789
  46. Usta Guc B, Cengiz N, Yildirim SV, Uslu Y. Cytomegalovirus infection in a patient with atypical Kawasaki disease. Rheumatol Int. 2008;28:387–389
  47. Catalano-Pons C, Quartier P, Leruez-Ville M, et al. Primary cytomegalovirus infection, atypical Kawasaki disease, and coronary aneurysms in 2 infants. Clin Infect Dis. 2005;41:53–56
  48. Kanegane H, Tsuji T, Seki H, et al. Kawasaki disease with a concomitant primary Epstein-Barr virus infection. Acta Paaediatr Jpn. 1994;36:713–716
  49. Benseler SM, McCrindle BW, Silverman ED, et al. Infections and Kawasaki disease: implications for coronary artery outcome. Pediatrics. 2005;116:e760–e766
  50. Burgner D, Harnden A. Kawasaki disease: what is the epidemiology telling us about the etiology?. Int J Infect Dis. 2005;9:185–194
  51. Simonini G, Rosè CD, Vierucci A, et al. Diagnosing Kawasaki syndrome: the need for a new clinical tool. Rheumatology. 2005;44:959–961
  52. Falcini F, Simonini G, De Simone L, et al. Atypical and incomplete Kawasaki disease: a challenge for pediatricians. Clin Exp Rheumatol. 2004;22:535;[abstract]
  53. Falcini F, Simonini G, Vitale A, et al. Facing the atypical/incomplete Kawasaki disease: what's the purpose?. Clin Exp Rheumatol. 2005;23:S55;[abstract]
  54. Kato H, Koike S, Yamamoto M, et al. Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. J Pediatr. 1975;86:892
  55. Asai T. Evaluation method for the degree of seriousness in Kawasaski disease. Acta Pediatr Jpn. 1983;25:170–175
  56. Feigin RD, Barron KD. Treatment of Kawasaki syndrome. New Engl J Med. 1986;315:388–390
  57. Song D, Yeo Y, Ha K, et al. Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age. Eur J Pediatr. 2009 Jan 22;[Epub ahead of print]
  58. Uehara R, Belay ED, Maddox RA, et al. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan. Pediatr Infect Dis J. 2008;27:155–160
  59. Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation. 1996;94:1379–1385
  60. Nakamura Y, Yanagawa H, Harada K, et al. Mortality among persons with a history of Kawasaki disease in Japan: the fifth look. Arch Pediatr Adolesc Med. 2002;156:162–165
  61. Furuyama H, Odagawa Y, Katoh C, et al. Assessment of coronary function in children with a history of Kawasaki disease using (15)O-water positron emission tomography. Circulation. 2002;105:2878–2884
  62. Tanaka N, Naoe S, Masuda H, Ueno T. Pathological study of sequelae of Kawasaki disease (MCLS) with special reference to the heart and coronary arterial lesions. Acta Pathol Jpn. 1986;36:1513–1527
  63. Kobayashi T, Inoue I, Otani T, et al. Risk stratification in the decision to include prednisolone with intravenous immunoglobulin in primary therapy in Kawasaki disease. Pediatr Infect Dis J. 2009;28:498–502
  64. Wang S, Best BM, Burns JC. Periungual desquamation in patients with Kawasaki disease. Pediatr Infect Dis J. 2009;28:538–539

PII: S1521-6942(09)00090-4

doi: 10.1016/j.berh.2009.08.010

Best Practice & Research Clinical Rheumatology
Volume 23, Issue 5 , Pages 689-697 , October 2009

Article Tools